News
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funds will be used to increase the company's research and development initiatives and expand its workforce.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.
Team members of New York Liberty, Las Vegas Aces and Dallas Wings will have access to licensed therapists, educational tools and resources.
The company will use the funds to speed up the commercialization of BiWaze Clear, scale U.S. sales initiatives, invest in clinical research and increase patient participation.
The partnership will allow Oura Ring wearers to share their biometric data with the virtual women's health company's care teams.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.